Atlas Trials

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

RecordFirmDate
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (NCT05363358)Takeda2022-05-27
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) (NCT05084053)Takeda2022-01-19
A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT04051944)UCB Biopharma SRL2019-08-21
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (NCT03864185)Nagoya University2019-03-28
A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (NCT03861481)UCB Biopharma S.P.R.L.2019-03-26

Track Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) automatically

Every clearance here is in the API, with alerts when new ones post.